相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Regulation of the activation of the Fanconi anemia pathway by the p21 cyclin-dependent kinase inhibitor
M. A. Rego et al.
ONCOGENE (2012)
Fra-1 controls motility of bladder cancer cells via transcriptional upregulation of the receptor tyrosine kinase AXL
A. E. Sayan et al.
ONCOGENE (2012)
Wip1 contributes to cell homeostasis maintained by the steady-state level of Wtp53
Hwan Ki Park et al.
CELL CYCLE (2011)
Orchestrating the nucleases involved in DNA interstrand cross-link (ICL) repair
Blanka Sengerova et al.
CELL CYCLE (2011)
SLX4, a coordinator of structure-specific endonucleases, is mutated in a new Fanconi anemia subtype
Chantal Stoepker et al.
NATURE GENETICS (2011)
Mutations of the SLX4 gene in Fanconi anemia
Yonghwan Kim et al.
NATURE GENETICS (2011)
beta-Catenin activation synergizes with PTEN loss to cause bladder cancer formation
I. Ahmad et al.
ONCOGENE (2011)
Milk fat globule-epidermal growth factor-factor VIII (MFGE8)/lactadherin promotes bladder tumor development
G. Sugano et al.
ONCOGENE (2011)
Nek6 overexpression antagonizes p53-induced senescence in human cancer cells
Hye Jin Jee et al.
CELL CYCLE (2010)
FAVL elevation in human tumors disrupts Fanconi anemia pathway signaling and promotes genomic instability and tumor growth
Jun Zhang et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Fanconi anemia and breast cancer susceptibility meet again
Ephrat Levy-Lahad
NATURE GENETICS (2010)
Mutation of the RAD51C gene in a Fanconi anemia-like disorder
Fiona Vaz et al.
NATURE GENETICS (2010)
Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene
Alfons Meindl et al.
NATURE GENETICS (2010)
AKT1 mutations in bladder cancer: identification of a novel oncogenic mutation that can co-operate with E17K
J. M. Askham et al.
ONCOGENE (2010)
Convergence of Rad6/Rad18 and Fanconi Anemia Tumor Suppressor Pathways upon DNA Damage
Hwan Ki Park et al.
PLOS ONE (2010)
FANCD2 monoubiquitination provides a link between the HHR6 and FA-BRCA pathways
Jun Zhang et al.
CELL CYCLE (2008)
Coordinate regulation of Fanconi anemia gene expression occurs through the Rb/E2F pathway
E. E. Hoskins et al.
ONCOGENE (2008)
FANCG promotes formation of a newly identified protein complex containing BRCA2, FANCD2 and XRCC3
J. B. Wilson et al.
ONCOGENE (2008)
p53 and retinoblastoma pathways in bladder cancer
Anirban P. Mitra et al.
WORLD JOURNAL OF UROLOGY (2007)
p53 gene and protein status:: The role of p53 alterations in predicting outcome in patients with bladder cancer
Ben George et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Emergence of a DNA-damage response network consisting of Fanconi anaemia and BRCA proteins
Weidong Wang
NATURE REVIEWS GENETICS (2007)
Phase II trial of sunitinib in bevacizumab-refractory metastatic renal cell carcinoma (mRCC): Updated results and analysis of circulating biomarkers
D. J. George et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Identification of the FANCI protein, a monoubiquitinated FANCD2 paralog required for DNA repair
Agata Smogorzewska et al.
CELL (2007)
FAAP100 is essential for activation of the Fanconi anemia-associated DNA damage response pathway
Chen Ling et al.
EMBO JOURNAL (2007)
Identification of FAAP24, a Fanconi anemia core complex protein that interacts with FANCM
Alberto Ciccia et al.
MOLECULAR CELL (2007)
Cancer statistics, 2007
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2007)
Altered expression of FANCL confers mitomycin C sensitivity in Calu-6 lung cancer cells
Jun Zhang et al.
CANCER BIOLOGY & THERAPY (2006)
Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2
Bing Xia et al.
MOLECULAR CELL (2006)
Regulation of DNA repair by ubiquitylation
TT Huang et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
Regulation of monoubiquitinated PCNA by DUB autocleavage
TT Huang et al.
NATURE CELL BIOLOGY (2006)
Matrix metalloproteinases and tumor metastasis
EI Deryugina et al.
CANCER AND METASTASIS REVIEWS (2006)
Molecular pathogenesis of Fanconi anemia: recent progress
Toshiyasu Taniguchi et al.
BLOOD (2006)
The Fanconi Anemia/BRCA pathway: new faces in the crowd
RD Kennedy et al.
GENES & DEVELOPMENT (2005)
BACH1 is critical for homologous recombination and appears to be the Fanconi anemia gene product FANCJ
R Litman et al.
CANCER CELL (2005)
A human ortholog of archaeal DNA repair protein Hef is defective in Fanconi anemia complementation group M
AR Meetei et al.
NATURE GENETICS (2005)
The DNA helicase BRIP1 is defective in Fanconi anemia complementation group J
M Levitus et al.
NATURE GENETICS (2005)
The anaemia of cancer: Death by a thousand cuts
JL Spivak
NATURE REVIEWS CANCER (2005)
New advances in the DNA damage response network of Fanconi anemia and BRCA proteins - FAAP95 replaces BRCA2 as the true FANCB protein
PW Fei et al.
CELL CYCLE (2005)
Heterogeneity in Fanconi anemia: evidence for 2 new genetic subtypes
M Levitus et al.
BLOOD (2004)
The ubiquitin-conjugating DNA repair enzyme HR6A is a maternal factor essential for early embryonic development in mice
HP Roest et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
A novel ubiquitin ligase is deficient in Fanconi anemia
AR Meetei et al.
NATURE GENETICS (2003)
Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumors
T Taniguchi et al.
NATURE MEDICINE (2003)
BRCA2 germline mutations in familial pancreatic carcinoma
SA Hahn et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
Biallelic inactivation of BRCA2 in Fanconi anemia
NG Howlett et al.
SCIENCE (2002)
Convergence of the Fanconi anemia and ataxia telangiectasia signaling pathways
T Taniguchi et al.
CELL (2002)
Positional cloning of a novel fanconi anemia gene, FANCD2
C Timmers et al.
MOLECULAR CELL (2001)
Arrest of S-phase progression is impaired in Fanconi anemia cells
M Sala-Trepat et al.
EXPERIMENTAL CELL RESEARCH (2000)
The Fanconi anaemia gene FANCF encodes a novel protein with homology to ROM
JP de Winter et al.
NATURE GENETICS (2000)